Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Smart materials have intrinsic properties that change in a controlled fashion in response to
external stimuli. Currently, the only smart materials with a significant clinical impact in …

The American College of Cardiology (ACC) develops a number of clinical policy documents
to provide members with guidance on clinical topics. Although clinical practice guidelines …

Background: There are limited data on the incidence, clinical implications, and predisposing
factors of transcatheter heart valve (THV) thrombosis following transcatheter aortic valve …

Objectives This study aimed to systematically assess the importance of left ventricular
outflow tract (LVOT) calcification on procedural outcomes and device performances with …

Transcatheter aortic valve replacement (TAVR) has replaced surgical aortic valve
replacement as the new gold standard in elderly patients with severe aortic valve stenosis …

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic
stenosis and is the treatment of choice for patients at prohibitive and high surgical risk …

Objective To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve
implantation in a large single-center cohort, including measurement of aortic valve …

Background Aortic valve calcification is supposed to be a possible cause of embolic stroke
or subclinical valve thrombosis after transcatheter aortic valve replacement (TAVR). We …

Transcatheter aortic valve implantation (TAVI) is the treatment of choice in patients with
symptomatic severe aortic stenosis who are either inoperable or at high risk for conventional …